January 30th - $Alaunos Therapeutics (TCRT.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from February 1st, 2024.
$Alaunos Therapeutics (TCRT.US)$ slipped 10.24% and closed at $0.1577 on January 29th with a turnover of $583.24K. $Alaunos Therapeutics (TCRT.US)$ now has a total market capitalization of $37.94 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.